{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T05:58:49Z","timestamp":1648792729300},"reference-count":8,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.eururo.2007.03.006","type":"journal-article","created":{"date-parts":[[2007,3,14]],"date-time":"2007-03-14T07:06:02Z","timestamp":1173855962000},"page":"1748-1750","source":"Crossref","is-referenced-by-count":1,"title":["Interview with Dr Richard Sylvester: Transition Cell Carcinoma of the Bladder"],"prefix":"10.1016","volume":"51","author":[{"given":"Christine","family":"McKillop","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2007.03.006_bib1","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2007.03.006_bib2","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1097\/01.ju.0000154696.48217.75","article-title":"Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder","volume":"173","author":"Shariat","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2007.03.006_bib3","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/jnci\/93.8.597","article-title":"Methods to improve efficacy of intravesical mitomycin C: results of a randomized phase III trial","volume":"93","author":"Au","year":"2001","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl 4","key":"10.1016\/j.eururo.2007.03.006_bib4","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0022-5347(18)33068-4","article-title":"Optimized intravesical mitomycin C treatment for superficial bladder cancer: long-term follow-up","volume":"175","author":"Au","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2007.03.006_bib5","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1200\/JCO.2003.01.089","article-title":"Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma","volume":"21","author":"Colombo","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2007.03.006_bib6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.eururo.2004.01.019","article-title":"Preliminary European results of local microwave hyperthermia and chemotherapy treatment in intermediate or high risk superficial transitional cell carcinoma of the bladder","volume":"46","author":"van der Heijden","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2007.03.006_bib7","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/01.ju.0000080568.91703.18","article-title":"Intravesical electromotive mitomycin C versus passive transport mitomycin C for high risk superficial bladder cancer: a prospective randomized study","volume":"170","author":"Di Stasi","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2007.03.006_bib8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1470-2045(05)70472-1","article-title":"Sequential BCG and electromotive mitomycin C versus BCG alone for high-risk superficial bladder cancer: a randomized controlled trial","volume":"7","author":"Di Stasi","year":"2006","journal-title":"Lancet Oncol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283807003594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283807003594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T23:35:45Z","timestamp":1556235345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283807003594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S0302283807003594"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2007.03.006","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}